Home devices may spot lung flare-ups before they become emergencies
NCT ID NCT07673237
First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time
Summary
This study tests whether people with fibrotic interstitial lung disease can use home monitoring devices—like a spirometer, pulse oximeter, and scale—to help detect serious lung events such as flare-ups or hospitalizations. About 200 participants will use these devices connected to a smartphone app. The goal is to see which combination of devices is most practical and acceptable for catching problems early.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- home monitoring devices (spirometer, pulse oximeter, wireless scale)
- What this could lead to
- If successful, this could show that remote monitoring is a practical way to catch serious lung flare-ups early, potentially improving care for people with interstitial lung disease.
- What could go wrong
- This is a feasibility study, not a treatment trial. It may find that home monitoring is not reliable enough or that patients struggle to use the devices consistently.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HYPERSENSITIVITY PNEUMONITIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of California, San Francisco
San Francisco, California, 94117, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart scans may unlock hidden risks in minority communities
- Can immune profiling unlock the hidden stages of tuberculosis?
- New imaging tracer could spot hidden cancers and fibrosis in one scan
- Massive study tracks lung disease progression in 4,000 patients
- 5,000 patients to help unlock secrets of inflammatory heart disease
- New PET tracer aims to reveal hidden immune activity in tumors and arteries